The board of directors of Beacon Pharmaceuticals Limited has recommended 5.0 per cent cash dividend for the year ended on June 30, 2017, said an official disclosure on Monday.
The final approval of dividend will come during the Annual General Meeting (AGM) scheduled to be held on December 28 at 11:00 am at Factory Premises in Mymensingh.
The record date for entitlement of dividend is on November 20, 2017.
The company has also reported earnings per share (EPS) of Tk 0.45, net asset value per share (NAV) per share of Tk 12.95 and net operating cash flow per share (NOCFPS) of Tk 4.25 for the year ended on June 30, 2017 as against Tk. 0.27, Tk. 13.00 and Tk. 2.41 respectively for the same period of the previous year.
There will be no price limit on the trading of the shares of the Company today (Monday) following its corporate declaration.
Each share of the company, which was listed on the Dhaka bourse in 2010 closed at Tk 21.70 each on Sunday at Dhaka Stock Exchange (DSE).
The company’s paid-up capital is Tk 2.31 billion and authorised capital is Tk 3.0 billion while total number of securities is 231 million.
The sponsor-directors own 30 per cent stake in the company, institutional investors own 15.83 per cent and the general public 54.17 per cent as on September 30, 2017, the DSE data shows.
